Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

British Pound (GBP) 0.8421 0.8337 Compare best Euro to British Pound exchange rates Australian Dollar (AUD) 1.7387 1.7213 Compare best Euro to Australian Dollar exchange rates Canadian Dollar (CAD ...

Compare the historical performance of various financial instruments, including shares, currencies and commodities. Click and drag to zoom.